GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Chase Sun Pharmaceutical Co Ltd (SZSE:300026) » Definitions » Book Value per Share

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Book Value per Share : ¥2.92 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Tianjin Chase Sun Pharmaceutical Co Book Value per Share?

Tianjin Chase Sun Pharmaceutical Co's book value per share for the quarter that ended in Mar. 2024 was ¥2.92.

During the past 12 months, Tianjin Chase Sun Pharmaceutical Co's average Book Value Per Share Growth Rate was 3.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 6.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 13.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Tianjin Chase Sun Pharmaceutical Co was 214.90% per year. The lowest was 4.30% per year. And the median was 15.00% per year.

Tianjin Chase Sun Pharmaceutical Co's current price is ¥3.37. Its book value per share for the quarter that ended in Mar. 2024 was ¥2.92. Hence, today's PB Ratio of Tianjin Chase Sun Pharmaceutical Co is 1.15.

During the past 13 years, the highest P/B Ratio of Tianjin Chase Sun Pharmaceutical Co was 10.00. The lowest was 1.14. And the median was 2.23.

Good Sign:

Tianjin Chase Sun Pharmaceutical Co Ltd stock PB Ratio (=1.24) is close to 10-year low of 1.16


Tianjin Chase Sun Pharmaceutical Co Book Value per Share Historical Data

The historical data trend for Tianjin Chase Sun Pharmaceutical Co's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Chase Sun Pharmaceutical Co Book Value per Share Chart

Tianjin Chase Sun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.26 2.40 2.59 2.76 2.90

Tianjin Chase Sun Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.82 2.85 2.90 2.90 2.92

Competitive Comparison of Tianjin Chase Sun Pharmaceutical Co's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Chase Sun Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Chase Sun Pharmaceutical Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Chase Sun Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Chase Sun Pharmaceutical Co's PB Ratio falls into.



Tianjin Chase Sun Pharmaceutical Co Book Value per Share Calculation

Tianjin Chase Sun Pharmaceutical Co's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(8,710-0)/3,004
=2.90

Tianjin Chase Sun Pharmaceutical Co's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(8,768-0)/3,004
=2.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Tianjin Chase Sun Pharmaceutical Co  (SZSE:300026) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Tianjin Chase Sun Pharmaceutical Co Book Value per Share Related Terms

Thank you for viewing the detailed overview of Tianjin Chase Sun Pharmaceutical Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Business Description

Traded in Other Exchanges
N/A
Address
No. 20, Quanfa Road, Tianjin Wuqing Development Area, Tianjin, CHN, 301700
Tianjin Chase Sun Pharmaceutical Co Ltd is a high-tech medicine and health industry group. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet-based therapy.
Executives
Yao Xiao Qing Director
Chen Rui Qiang Executives
Li Chun Xu Executives
Lan Wu Jun Directors, Directors, and Executives
Zheng Dan Directors, executives
Zhang Kun Executives
Gao Guo Wei Executives
Shang Xiao Mei Securities Affairs Representative
Sun Zhang Hai Director
Wu Guang Ning Supervisors
Wang Long Executives
Liu Qiang Supervisors
Ceng Guo Zhuang Director
Su Bing Jun Directors, executives
Nie Wei Supervisors

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Headlines

No Headlines